128 related articles for article (PubMed ID: 26604658)
1. Hepatitis C eradication: A long way to go.
Waheed Y
World J Gastroenterol; 2015 Nov; 21(43):12510-2. PubMed ID: 26604658
[TBL] [Abstract][Full Text] [Related]
2. Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America.
Panduro A; Roman S
World J Gastroenterol; 2016 Jun; 22(22):5137-42. PubMed ID: 27298556
[TBL] [Abstract][Full Text] [Related]
3. Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakers.
Gupta N; Swindells S; Scarsi KK; Furl R; Thomas DL; Weld ED; Ofimboudem JD; Desalegn H; Hamid S; Rosas AT; Miranda AE; Owen A; Rannard S; Hiebert L; Sun K; Ward JW
J Viral Hepat; 2024 May; 31(5):221-232. PubMed ID: 38545826
[TBL] [Abstract][Full Text] [Related]
4. Global Elimination of HCV-Why Is Poland Still So Far from the Goal?
Tronina O; Panczyk M; Zarębska-Michaluk D; Gotlib J; Małkowski P
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896844
[TBL] [Abstract][Full Text] [Related]
5. Prospects for Long-Acting Treatments for Hepatitis C.
Thomas DL; Owen A; Kiser JJ
Clin Infect Dis; 2022 Nov; 75(Suppl 4):S525-S529. PubMed ID: 36410380
[TBL] [Abstract][Full Text] [Related]
6. Global control of hepatitis C: where challenge meets opportunity.
Thomas DL
Nat Med; 2013 Jul; 19(7):850-8. PubMed ID: 23836235
[TBL] [Abstract][Full Text] [Related]
7. The Ethics of Precision Rationing: Human Genetics and the Need for Debate on Stratifying Access to Medication.
Walker A; Boyce A; Duggal P; Thio CL; Geller G
Public Health Genomics; 2020; 23(3-4):149-154. PubMed ID: 32516789
[TBL] [Abstract][Full Text] [Related]
8. Editorial: Hepatitis C virus eradication improves skeletal muscle mass-Authors' reply.
Coelho MPP; de Vries TP; Pires AM; Parreira MP; de Alvarenga ÉR; Cambraia RD; Dos Santos RR; Bezerra JMT; Colosimo EA; Rocha GA; Silva LD
Aliment Pharmacol Ther; 2024 Jun; 59(11):1448-1450. PubMed ID: 38711360
[No Abstract] [Full Text] [Related]
9. England on track to eliminate hepatitis C.
Burki TK
Lancet Oncol; 2023 Jan; 24(1):16. PubMed ID: 36502813
[No Abstract] [Full Text] [Related]
10. Hepatitis C virus: A global view.
Mohamed AA; Elbedewy TA; El-Serafy M; El-Toukhy N; Ahmed W; Ali El Din Z
World J Hepatol; 2015 Nov; 7(26):2676-80. PubMed ID: 26609344
[TBL] [Abstract][Full Text] [Related]
11. An update on hepatitis C virus.
Klenerman P; Fitzmaurice K
Clin Med (Lond); 2015 Dec; 15 Suppl 6():s33-6. PubMed ID: 26634679
[TBL] [Abstract][Full Text] [Related]
12. Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.
Höner Zu Siederdissen C; Maasoumy B; Marra F; Deterding K; Port K; Manns MP; Cornberg M; Back D; Wedemeyer H
Clin Infect Dis; 2016 Mar; 62(5):561-7. PubMed ID: 26611779
[TBL] [Abstract][Full Text] [Related]
13. Once-a-Day Harvoni (Ledipasvir plus Sofosbuvir), a New Oral Combination for the Treament of Patients with Genotype 1 Chronic Hepatitis C Infection.
Raedler LA
Am Health Drug Benefits; 2015 Mar; 8(Spec Feature):54-8. PubMed ID: 26629267
[No Abstract] [Full Text] [Related]
14. Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015.
Puri P; Anand AC; Saraswat VA; Acharya SK; Dhiman RK; Sarin SK; Singh SP; Chawla YK; Aggarwal R; Amarapurkar D; Arora A; Dixit VK; Sood A; Shah S; Duseja A; Kapoor D; Shalimar ; Madan K; Pande G; Nagral A; Kar P; Koshy A; Puri AS; Eapen CE; Thareja S
J Clin Exp Hepatol; 2015 Sep; 5(3):221-38. PubMed ID: 26628840
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus.
Matsumura T; Sugiyama N; Murayama A; Yamada N; Shiina M; Asabe S; Wakita T; Imawari M; Kato T
Hepatol Res; 2016 Aug; 46(9):924-32. PubMed ID: 26606891
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C: Is eradication possible?
Lombardi A; Mondelli MU;
Liver Int; 2019 Mar; 39(3):416-426. PubMed ID: 30472772
[TBL] [Abstract][Full Text] [Related]
17. Molecular surveillance of HCV mono-infection and HCV-HBV co-infection in symptomatic population at Hyderabad, Pakistan.
Patoli BB; Patoli AA; Balani NK; Korejo AA
Afr Health Sci; 2018 Sep; 18(3):531-538. PubMed ID: 30602984
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis elimination by 2030: Progress and challenges.
Waheed Y; Siddiq M; Jamil Z; Najmi MH
World J Gastroenterol; 2018 Nov; 24(44):4959-4961. PubMed ID: 30510370
[TBL] [Abstract][Full Text] [Related]
19. Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension.
Agrawal B; Singh S; Gupta N; Li W; Vedi S; Kumar R
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749434
[TBL] [Abstract][Full Text] [Related]
20. A novel benzo-heterocyclic amine derivative N30 inhibits influenza virus replication by depression of Inosine-5'-Monophospate Dehydrogenase activity.
Hu J; Ma L; Wang H; Yan H; Zhang D; Li Z; Jiang J; Li Y
Virol J; 2017 Mar; 14(1):55. PubMed ID: 28298229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
